BioMimics 3D Vascular Stent System

Stent, Superficial Femoral Artery

FDA Premarket Approval P180003

Pre-market Approval Supplement Details

Approval for the biomimics 3d vascular stent system. The device is indicated to improve luminal diameter in the treatment of symptomatic de novo or restenotic lesions in the native superficial femoral artery and/or proximal popliteal arteries, with reference vessel diameters ranging from 4. 0 - 6. 0 mm and lesion lengths up to 140 mm.

DeviceBioMimics 3D Vascular Stent System
Classification NameStent, Superficial Femoral Artery
Generic NameStent, Superficial Femoral Artery
ApplicantVeryan Medical Ltd.
Date Received2018-01-09
Decision Date2018-10-04
Notice Date2018-10-19
PMAP180003
SupplementS
Product CodeNIP
Docket Number18M-3841
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address Veryan Medical Ltd. unit 15, City Business Centre, Brighton Rd horsham RH13
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P180003Original Filing
S006 2022-03-09 30-day Notice
S005 2021-10-14 Normal 180 Day Track
S004 2021-03-17 30-day Notice
S003 2020-06-25 Normal 180 Day Track No User Fee
S002 2020-03-16 30-day Notice
S001 2020-03-02 30-day Notice

NIH GUDID Devices

Device IDPMASupp
05391526850527 P180003 000
05391526850398 P180003 000
05391526850404 P180003 000
05391526850411 P180003 000
05391526850428 P180003 000
05391526850435 P180003 000
05391526850442 P180003 000
05391526850459 P180003 000
05391526850466 P180003 000
05391526850473 P180003 000
05391526850480 P180003 000
05391526850497 P180003 000
05391526850503 P180003 000
05391526850510 P180003 000
05391526850381 P180003 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.